We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab.
- Authors
Odom, Dawn; Barber, Beth; Bennett, Lee; Peeters, Marc; Zhao, Zhongyun; Kaye, James; Wolf, Michael; Wiezorek, Jeffrey
- Abstract
Panitumumab monotherapy is approved for chemotherapy-refractory wild-type KRAS metastatic colorectal cancer (mCRC). Patient-reported outcomes-although important in the palliative setting-have not been reported in this patient population.
- Publication
International journal of colorectal disease, 2011, Vol 26, Issue 2, p173
- ISSN
1432-1262
- Publication type
Journal Article
- DOI
10.1007/s00384-010-1112-5